Responses to endothelium-dependent agonists in subcutaneous arteries excised from hypercholesterolaemic men

British Journal of Pharmacology

Volumn 124, Issue 1, 1998, Pages 222-228

  Lewis, Tamara V ^a   Cooper, Bridget A ^a   Dart, Anthony M ^a   Chin Dusting, Jaye P F ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Acetylcholine; Arginine; Hypercholesterolaemia; Nitric oxide; Resistance arteries; Substance P

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN A1; ARGININE; CHOLESTEROL; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; SUBSTANCE P; VASODILATOR AGENT;

ADULT; ARTERY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; MALE; MYOGRAPHY; PRIORITY JOURNAL; SKIN BIOPSY; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

ACETYLCHOLINE; ARTERIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; MALE; NITROPRUSSIDE; NOREPINEPHRINE; SUBSTANCE P; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031919618     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701800     Document Type: Article

References (28)

1. BOSSALLER, B., HABIB, G.B., YAMAMOTO, H., WILLIAMS, C., WELLS, S. & HENRY, P.D. (1987). Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artry and rabbit aorta. J. Clin. Invest., 79, 170-174.
2. BULT, H., DE MEYER, G.R.Y. & HERMAN, A.G. (1995). Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta. Br. J. Pharmacol., 114, 1371-1382.
3. CASINO, P.R., KILCOYNE, C.M., QUYYUMI, A.A., HOEG, J.M. & PANZA, J.A. (1994). Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilatation in hypercholesterolemic patients. J. Am. Coll. Cardiol., 23, 844-850.
4. CASTELLI, W., GARRISON, R., WILSON, P., ABBOTT, R., KALOUSDIAN, S. & KANNEL, W. (1986). Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. J. Am. Med. Assoc., 256, 2835 2838.
5. CHIN, J., KAYE, D., HURLSTON, R., ANGUS, J., JENNINGS, G. & DART, A. (1994). Effects of dietary marine oil supplementation on reactivity of human buttock subcutaneous arteries and forearm veins in vitro. Br. J. Pharmacol., 112, 566 570.
6. CHIN, J.H., AZHAR, S. & HOFFMAN, B.B. (1992). Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest., 89, 10 18.
7. CHIN, J.P.F. & DART, A.M. (1994). Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils. Clin. Exp. Pharmacol. Physiol., 21, 749 755.
8. CHIN-DUSTING, J., ALEXANDER, C., ARNOLD, P., HODGSON, W., LUX, A. & JENNINGS, G. (1996). Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. J. Cardiovasc. Pharmacol., 28, 158 166.
9. CHOWIENCZYK, P.J., WATTS, G.F., COCKCROFT, J.R. & RITTER, J.M. (1992). Impaired endothelium-dependent vasodilatation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1430-1432.
10. CREAGER, M.A., COOKE, J.P., MENDELSOHN, M.E., GALLAGHER, S.J., COLEMAN, S.M., LOSCALZO, J. & DZAU, V.J. (1990). Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest., 86, 228 234.
11. CREAGER, M.A., GALLAGHER, S.J., GIRERD, X.J., COLEMAN, S.M., DZAU, V.J. & COOKE, J.P. (1992). L-Arginine improves endothelium-dependent vasodilatation in hypercholesterolemic humans. J. Clin. Invest., 90, 1248 1253.
12. CROSSMAN, D.C., LARKIN, S.W., DASHWOOD, M., DAVIES, G.J., YACOUB, M. & MASERI, A. (1989). Atherosclerotic human coronary vessels preserve a dilator response to substance P in vivo. Br. Heart J., 61, 455 456.
13. DREXLER, H. & ZEIHER, A.M. (1991). Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension, 18, 11-90 11-99.
14. DREXLER, H., ZEIHER, A.M., MEINZER, K. & JUST, H. (1991). Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet, 338, 1546 1560.
15. FLAVAHAN, N. (1992). Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/Nitric Oxide activity. Circulation, 85, 1927 1938.
16. GALLE, J., MULSCH, A., BUSSE, R. & BASSENGE, E. (1991). Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterio. Thromb., 11, 198 203.
17. GOODE, G. & HEAGERTY, A. (1995). In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation, 91, 2898 2903.
18. LEUNG, W., LAU, C.-P. & WONG, C.-K. (1993). Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet, 341, 1496 1500.
19. LIAO, J. (1994). Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J. Biol. Chem., 269, 12987 12992.
20. MACDONALD, S., DUMAS, J. & BOYD, N. (1996). Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins Gq and G11. Biochemistry, 35, 2909 2916.
21. MONCADA, S., PALMER, R.M.J. & HIGGS, K.A. (1991). Nitric oxide: physiology, pathology and pharmacology. Pharmacol. Rev., 43, 109 142.
22. MULVANY, M. & WARSHAW, D. (1979). The active tension-length curve of vascular smooth muscle-related to its cellular components. J. Gen. Physiol., 74, 85 104.
23. NAKASHIMA, A., ANGUS, J. & JOHNSTON, C. (1982). Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur. J. Pharmacol., 81, 487 492.
24. O'DRISCOLL, G., GREEN, D. & TAYLOR, R. (1997). Simvastatin. an HMG-Coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation, 95, 1126 1131.
25. SATTLER, W., BONE, O. & STOCKER, R. (1992). Isolution of human VLDL, LDL, HDL and two HDL subclasses in the TL-100 tabletop centrifuge using TLA-100.4 rotor. Beckman Instruments Technical Bulletin, DS-850. California: Beckman Instruments Inc.
26. SHERRARD, B., SIMPSON, H., CAMERON, J., WAHI, S., JENNINGS, G. & DART. A. (1996). LDL particle size in subjects with previously unsuspected coronary heart disease: relationship with other cardiovascular risk markers. Atherosclerosis, 126, 277 287.
27. TAMAI, O., MATSUOKA, H., ITABE, H., WADA, Y., KOHNO, K. & IMAIZUMI, T. (1997). Single LDL apharesis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 95, 76 82.
28. URAKAMI-HARASAWA, L., SHIMOKAWA, H., NAKASHIMA, M., EGASHIRA, K. & TAKESHITA. A (1997). Importance of endothelium-derived hyperpolarizing factor in human arteries. J. Clin, Invest., 100, 2793 2799.